metoprolol has been researched along with Palmoplantaris Pustulosis in 9 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have learned that she was prescribed metoprolol at another medical center to treat new onset hypertension." | 3.78 | Palmar psoriasis, a rare side effect of beta-blocker theraphy: a case report. ( Demirkan, B; Güray, U; Güray, Y; Refiker Ege, M, 2012) |
| "Oral provocation tests revealed the relation between long-term oral use of metoprolol and development of psoriasiform and/or eczematous skin lesions in 3 patients." | 3.66 | Adverse reactions of the skin to metoprolol and other beta-adrenoreceptor-blocking agents. ( Neumann, HA; van Joost, T, 1981) |
| "Down syndrome is a genetic disorder known to cause many complications with lifelong effects." | 1.51 | Down syndrome, severe psoriasis, and increased risk for cardiovascular events. ( DʼAcunto, K; Sismour, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sismour, B | 1 |
| DʼAcunto, K | 1 |
| Schmutz, JL | 1 |
| Trechot, P | 1 |
| Doyon, JB | 1 |
| Liu, KJ | 1 |
| Berman, RA | 1 |
| Gin, A | 1 |
| Gin, D | 1 |
| Sinclair, R | 1 |
| Refiker Ege, M | 1 |
| Güray, Y | 1 |
| Güray, U | 1 |
| Demirkan, B | 1 |
| Fux, R | 1 |
| Mörike, K | 1 |
| Pröhmer, AM | 1 |
| Delabar, U | 1 |
| Schaeffeler, E | 1 |
| Gleiter, CH | 1 |
| Schwab, M | 1 |
| Neumann, HA | 1 |
| van Joost, T | 1 |
| Maisano, G | 1 |
| Tassini, T | 1 |
| Altomare, GF | 1 |
| Gandossi, E | 1 |
| Pigatto, PD | 1 |
| Polenghi, MM | 1 |
1 trial available for metoprolol and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Psoriasis aggravation and metoprolol treatment -- a prospective observational case study.
Topics: Adult; Cytochrome P-450 CYP2D6; Dermatologic Agents; Female; Genotype; Humans; Male; Metoprolol; Mid | 2007 |
8 other studies available for metoprolol and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Down syndrome, severe psoriasis, and increased risk for cardiovascular events.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Down Syndrome; Fat | 2019 |
[Isolated ungual psoriasis and metoprolol].
Topics: Adrenergic beta-1 Receptor Antagonists; Female; Humans; Metoprolol; Middle Aged; Nail Diseases; Psor | 2013 |
Metoprolol-induced Total Body Erythroderma.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Dermatitis, Exfoliative; Drug | 2017 |
Metoprolol-induced psoriatic nail disease.
Topics: Anti-Arrhythmia Agents; Female; Humans; Metoprolol; Middle Aged; Nail Diseases; Psoriasis; Tachycard | 2013 |
Palmar psoriasis, a rare side effect of beta-blocker theraphy: a case report.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Iatrogenic Disease; Metoprolol; Psoriasis | 2012 |
Adverse reactions of the skin to metoprolol and other beta-adrenoreceptor-blocking agents.
Topics: Adrenergic beta-Antagonists; Eczema; Fluorescent Antibody Technique; Humans; Male; Metoprolol; Middl | 1981 |
[Psoriasis and metoprolol].
Topics: Humans; Metoprolol; Psoriasis | 1984 |
[Correlations between beta blockers and the induction of psoriasis].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Humans; Male; Metoprolol; Middle Aged; Propranolol; Pso | 1987 |